Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elea Labs is a Swiss longevity science company that integrates clinical dermatology with data-driven technology to optimize human healthspan. The company utilizes the skin as a primary biomarker for biological aging, developing personalized diagnostic tools and evidence-based formulations. Their approach combines advanced biotechnology with digital health platforms to provide actionable insights into the aging process. Elea Labs focuses on bridging the gap between longevity research and practical health applications for consumers and clinicians. By leveraging clinical research and AI-driven analytics, the company aims to redefine preventive medicine through the lens of skin health and longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elea Labs.